These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 8388600

  • 21. Estrogen treatment of excessively tall girls with Marfan syndrome.
    Knudtzon J, Aarskog D.
    Acta Paediatr Scand; 1988 Jul; 77(4):537-41. PubMed ID: 3394507
    [Abstract] [Full Text] [Related]

  • 22. Haemostatic changes in tall girls treated with high doses of ethinyloestradiol.
    Muntean W, Borkenstein M.
    Eur J Pediatr; 1980 Sep; 134(3):245-8. PubMed ID: 6775950
    [Abstract] [Full Text] [Related]

  • 23. Growth-reductive therapy in children with marfan syndrome.
    Rozendaal L, le Cessie S, Wit JM, Hennekam RC, The Dutch Marfan Working Group.
    J Pediatr; 2005 Nov; 147(5):674-9. PubMed ID: 16291362
    [Abstract] [Full Text] [Related]

  • 24. [Treatment of constitutionally tall girls with physiological estrogen doses in the prepuberty period. An alternative to high-dose estrogen therapy].
    Schambach H, Nitschke U.
    Monatsschr Kinderheilkd; 1985 Jan; 133(1):32-7. PubMed ID: 3974582
    [Abstract] [Full Text] [Related]

  • 25. [The results of sex steroid therapy to reduce the final height of tall-stature girls at the University Pediatric Clinic in Leipzig].
    Hoepffner W, Willgerodt H, Keller E, Kahleyss S.
    Padiatr Grenzgeb; 1990 Jan; 29(2):141-3. PubMed ID: 2352742
    [Abstract] [Full Text] [Related]

  • 26. [Continuous intravenous infusion of insulin to girls with hereditary tall growth and secretion of human growth hormone, prior to and during Deposiston treatment (author's transl)].
    Richter J, Heine W, Rudolf K, Uhlmann M.
    Zentralbl Gynakol; 1980 Jan; 102(19):1117-20. PubMed ID: 7008461
    [Abstract] [Full Text] [Related]

  • 27. Estrogen treatment of tall girls: dose dependency of effects on subsequent growth and IGF-I levels in blood.
    Svan H, Ritzén EM, Hall K, Johansson L.
    Acta Paediatr Scand; 1991 Mar; 80(3):328-32. PubMed ID: 2035328
    [Abstract] [Full Text] [Related]

  • 28. Oestrogen treatment of adolescent tall girls; short term side effects.
    Trygstad O.
    Acta Endocrinol Suppl (Copenh); 1986 Mar; 279():170-3. PubMed ID: 3465158
    [Abstract] [Full Text] [Related]

  • 29. Estrogen treatment of tall stature in girls with the Marfan syndrome.
    Skovby F, McKusick VA.
    Birth Defects Orig Artic Ser; 1977 Mar; 13(3C):155-61. PubMed ID: 196698
    [No Abstract] [Full Text] [Related]

  • 30. Treatment of tall stature in boys with somatostatin analogue 201-995: effect on final height.
    Noordam C, van Daalen S, Otten BJ.
    Eur J Endocrinol; 2006 Feb; 154(2):253-7. PubMed ID: 16452538
    [Abstract] [Full Text] [Related]

  • 31. Hormonal changes during the first year of oestrogen treatment in constitutionally tall girls.
    Wajs-Kuto E, De Beeck LO, Rooman RP, Caju MV.
    Eur J Endocrinol; 1999 Dec; 141(6):579-84. PubMed ID: 10601959
    [Abstract] [Full Text] [Related]

  • 32. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
    Poomthavorn P, Suphasit R, Mahachoklertwattana P.
    Gynecol Endocrinol; 2011 Aug; 27(8):524-8. PubMed ID: 21501002
    [Abstract] [Full Text] [Related]

  • 33. [Estrogen treatment of excessively tall girls (author's transl)].
    Klittich L, Lehr HJ, Schmidt-Elmendorff H, Steyer M.
    Geburtshilfe Frauenheilkd; 1978 Oct; 38(10):831-9. PubMed ID: 212344
    [Abstract] [Full Text] [Related]

  • 34. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
    Nilsson KO, Albertsson-Wikland K, Alm J, Aronson S, Gustafsson J, Hagenäs L, Häger A, Ivarsson SA, Karlberg J, Kriström B, Marcus C, Moell C, Ritzen M, Tuvemo T, Wattsgård C, Westgren U, Westphal O, Aman J.
    J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
    [Abstract] [Full Text] [Related]

  • 35. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.
    Cacciari E, Mazzanti L.
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710
    [Abstract] [Full Text] [Related]

  • 36. Outcome in tall stature. Final height and psychological aspects in 220 patients with and without treatment.
    Binder G, Grauer ML, Wehner AV, Wehner F, Ranke MB.
    Eur J Pediatr; 1997 Dec; 156(12):905-10. PubMed ID: 9453370
    [Abstract] [Full Text] [Related]

  • 37. Estrogen therapy in Turner's syndrome.
    Cutler GB, Ross JL.
    Acta Paediatr Jpn; 1992 Apr; 34(2):195-202; discussion 202-5. PubMed ID: 1621525
    [Abstract] [Full Text] [Related]

  • 38. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
    Quigley CA, Crowe BJ, Anglin DG, Chipman JJ.
    J Clin Endocrinol Metab; 2002 May; 87(5):2033-41. PubMed ID: 11994337
    [Abstract] [Full Text] [Related]

  • 39. Studies in constitutionally tall adolescents. II. Effects of bromocriptine on growth hormone secretion and adult height prediction.
    Evain-Brion D, Garnier P, Blanco-Garcia M, Job JC.
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1022-6. PubMed ID: 6427255
    [Abstract] [Full Text] [Related]

  • 40. Referrals for tall stature in children: a 25-year personal experience.
    Thomsett MJ.
    J Paediatr Child Health; 2009 Jun; 45(1-2):58-63. PubMed ID: 19208068
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.